EurekaMag.com logo
+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The effect of thalidomide analogue CC-3052 on apoptosis of lymphocytes and neutrophils in HIV



The effect of thalidomide analogue CC-3052 on apoptosis of lymphocytes and neutrophils in HIV



Immunology 92(SUPPL 1): 3




(PDF emailed within 1 workday: $29.90)

Accession: 033785236

Download citation: RISBibTeXText



Related references

Thalidomide analogue CC-3052 reduces apoptosis in neutrophils from normal and HIV+ donors in vitro. Immunology 95(SUPPL 1): 85, 1998

Thalidomide analogue CC-3052 reduces HIV+ neutrophil apoptosis in vitro. Clinical & Experimental Immunology 121(3): 472-479, September, 2000

Effect of thalidomide on apoptosis of lymphocytes and neutrophils. Immunopharmacology and Immunotoxicology 19(3): 313-326, 1997

The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro. Clinical and Experimental Immunology 119(1): 123-129, 1999

The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro. Clinical and Experimental Immunology 119(1): 123-129, 2000

Thalidomide analog 3052 reduces NK activity and PHA-induced proliferation in vitro. Immunology 89(SUPPL 1): 34, 1996

CC-3052: a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-a production. Journal of Immunology 161(8): 36-43, 1998

The neutropenia induced by the thalidomide analogue CC-4047 in patients with multiple myeloma is associated with an increased percentage of neutrophils bearing CD64. International Immunopharmacology 6(7): 1194-1203, 2006

CC-3052: a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha production. Journal of Immunology 161(8): 4236-4243, 1998

In vitro reduction of accelerated apoptosis of neutrophils in blood drawn from an HIV positive subject with Thalidomide. FASEB Journal 15(4): A556, March 7, 2001

A novel subclass of thalidomide analogue with anti-solid tumour activity in which caspase dependent apoptosis is associated with altered expression of bcl-2 family proteins. British Journal of Cancer 86(Supplement 1): S117-S118, June, 2002

A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins. Cancer Research 63(3): 593-599, 2003

Combined radiotherapy and thalidomide or the thalidomide analogue 3APG in an intracranial glioblastoma model. Proceedings of the American Association for Cancer Research Annual Meeting 43: 480, March, 2002

Thalidomide and a thalidomide analogue drug costimulate virus-specific CD8+ T cells in vitro. Journal of Infectious Diseases 187(6): 946-955, 2003